Peptide-Based Vaccines for Hepatocellular Carcinoma: A Review of Recent Advances

Primary liver cancer is the sixth most commonly diagnosed cancer and the third leading cause of cancer-related deaths worldwide. After surgery, up to 70% of patients experience relapses. The current first-line therapy for advanced cases of hepatocellular carcinoma (HCC) comprises sorafenib and lenva...

Descripción completa

Detalles Bibliográficos
Autores principales: Charneau, Jimmy, Suzuki, Toshihiro, Shimomura, Manami, Fujinami, Norihiro, Nakatsura, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424432/
https://www.ncbi.nlm.nih.gov/pubmed/34513746
http://dx.doi.org/10.2147/JHC.S291558

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8424432/
https://www.ncbi.nlm.nih.gov/pubmed/34513746
http://dx.doi.org/10.2147/JHC.S291558

Ejemplares similares